- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Lixisenatide – July 2014
Lixisenatide,10 microgram/0.2 mL injection, 14 unit doses (&) 20 microgram/0.2 mL injection, 14 unit doses, Lyxumia® treatment initiation pack; Lixisenatide, 20 microgram/0.2 mL injection, 2 x 14 unit doses,Lyxumia®, Sanofi-Aventis Australia Pty Ltd
Last updated
8 November 2023